# Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

> **NCT00380575** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 84 (—)

## Conditions studied

- Hyponatremia

## Interventions

- **DRUG:** YM087

## Key facts

- **NCT ID:** NCT00380575
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2003-02
- **Target enrollment:** 84 (—)
- **Last updated:** 2014-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380575, "Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00380575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*